Efficacy and safety of chemotherapy or tyrosine kinase inhibitors combined with bevacizumab versus chemotherapy or tyrosine kinase inhibitors alone in the treatment of non-small cell lung cancer: a systematic review and meta-analysis.
about
Meta-analysis of the impact of de novo and acquired EGFR T790M mutations on the prognosis of patients with non-small cell lung cancer receiving EGFR-TKIs.Anti-angiogenesis therapy and gap junction inhibition reduce MDA-MB-231 breast cancer cell invasion and metastasis in vitro and in vivo.Wasted research when systematic reviews fail to provide a complete and up-to-date evidence synthesis: the example of lung cancer.Efflux transporter variants as predictors of drug toxicity in lung cancer patients: systematic review and meta-analysis.A phase I study of afatinib combined with paclitaxel and bevacizumab in patients with advanced solid tumors.Epidermal growth factor receptor mutation enhances expression of vascular endothelial growth factor in lung cancer.Whole genome gene expression changes and hematological effects of rikkunshito in patients with advanced non-small cell lung cancer receiving first line chemotherapy.Management Strategies for Adverse Events Associated With EGFR TKIs in Non-Small Cell Lung Cancer.[Research Advances of Pan-negative Type of Non-small Cell Lung Cancer].Clinical Safety of Combined Targeted and L. Therapy in Oncological Patients
P2860
Q33621143-81398375-778C-4EE9-AE8E-1ACC51DC5E52Q35896210-32D8448E-C919-458A-BCB4-F351828AA975Q35899612-AB4AE29C-8D2E-43F2-9D1A-2447C6E983CFQ36043023-C6636D5C-ABC5-4D52-914F-D0F3170F471CQ37578362-DFCCF078-9AA3-4FF8-8DCE-F4E48BC427BBQ37581685-7DA7849E-333C-4E6C-903D-7B2E7BE2FDC2Q41672333-B1249AA8-E2DE-4D45-8817-3DA7CC51D11BQ54166640-72DA78AE-4E90-45A7-B9A3-CD4A8B5D0157Q55496722-50D076DB-3D62-4D30-97C5-70D8DA7C1FDCQ58760840-57E5A71F-28CD-4BC6-84E0-D4A09EE06C71
P2860
Efficacy and safety of chemotherapy or tyrosine kinase inhibitors combined with bevacizumab versus chemotherapy or tyrosine kinase inhibitors alone in the treatment of non-small cell lung cancer: a systematic review and meta-analysis.
description
2015 nî lūn-bûn
@nan
2015 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Efficacy and safety of chemoth ...... atic review and meta-analysis.
@ast
Efficacy and safety of chemoth ...... atic review and meta-analysis.
@en
type
label
Efficacy and safety of chemoth ...... atic review and meta-analysis.
@ast
Efficacy and safety of chemoth ...... atic review and meta-analysis.
@en
prefLabel
Efficacy and safety of chemoth ...... atic review and meta-analysis.
@ast
Efficacy and safety of chemoth ...... atic review and meta-analysis.
@en
P2093
P2860
P1433
P1476
Efficacy and safety of chemoth ...... atic review and meta-analysis.
@en
P2093
Cheng-Bo Han
Hua-Wei Zou
Jie-Tao Ma
Shu-Ling Zhang
P2860
P2888
P356
10.1007/S12032-014-0473-Y
P577
2015-01-21T00:00:00Z